The role of cell-free DNA in fibrinolysis for intraventricular hemorrhage

被引:6
|
作者
Xie, Fangke [1 ]
Tan, Qiang [2 ]
Yu, Anyong [1 ]
Guo, Peiwen [2 ]
Wang, Ling [2 ]
Zeng, Zongwei [2 ]
Liang, Liang [2 ]
Xian, Jishu [2 ]
Feng, Hua [2 ]
Chen, Zhi [2 ]
机构
[1] Zunyi Med Univ, Affiliated Hosp, Dept Emergency, Zunyi, Peoples R China
[2] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
intraventricular hemorrhage; tissue plasminogen activator; neutrophil extracellular traps; cell-free DNA; fibrinolysis; vascular disorders; NEUTROPHIL EXTRACELLULAR TRAPS; TISSUE-PLASMINOGEN ACTIVATOR; CITRULLINATED HISTONE H3; CANINE MODEL; BLOOD-CLOT; UROKINASE; HEMATOMA; LYSIS; THERAPY;
D O I
10.3171/2020.7.JNS201429
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Tissue plasminogen activator (tPA) fibrinolysis did not improve functional outcomes of patients with intraventricular hemorrhage (IVH), largely because of the unsatisfactory clot clearance. The presence of neutrophil extracellular traps (NETs) within the clot has been confirmed to impair tPA fibrinolysis, but the mechanism has been unclear. The authors hypothesized that cell-free DNA (cfDNA), the main framework of NETs, might be the important reason for the fibrinolysis resistance, and they validated the hypothesis, hoping to provide a new target to promote intraventricular fibrinolysis. METHODS First, cfDNA was detected in IVH clots by immunofluorescence staining in a rat model of IVH. Second, after blood (with or without exogenous cfDNA) intraventricular injection, IVH rats were given intraventricular infusion of 2 mu l of saline, tPA, or tPA + DNase1 randomly. Then, the ventricular volume, animal behavior, and reactive astrocyte proliferation were assessed. Third, the IVH clots were collected for fibrinolysis assay in vitro. Finally, the effects of exogenous cfDNA in IVH were evaluated. RESULTS The presence of cfDNA in clots was observed as early as 1 hour after IVH. Compared with the whole-blood model, blood + cfDNA caused more severe ventricular dilation (day 7: blood 32.47 +/- 2.096 mm(3) vs blood + DNA 40.09 +/- 2.787 mm(3), p < 0.05), increased fibrinolysis resistance to tPA (day 7: tPA + DNA 26.04 +/- 1.318 mm(3) vs tPA 22.15 +/- 1.706 mm(3), p < 0.05), and further deteriorated the functional defects in rats (blood vs blood + DNA, p < 0.05). Degradation of cfDNA by DNase1 further enhanced the fibrinolysis effects on relieving the ventricular dilation (day 7: tPA + DNase1 11.67 +/- 2.023 mm(3) vs tPA, p < 0.05), improving the functional outcome (tPA vs tPA + DNase1, p < 0.05) and reducing periventricular astrocyte proliferation. CONCLUSIONS cfDNA impaired tPA fibrinolysis for IVH, and degradation of cfDNA may be a new target to improve this condition.
引用
收藏
页码:1105 / 1112
页数:8
相关论文
共 50 条
  • [21] Secondary hemorrhage after intraventricular fibrinolysis: A cautionary note: A report of two cases
    Schwarz, S
    Schwab, S
    Steiner, HH
    Hacke, W
    NEUROSURGERY, 1998, 42 (03) : 659 - 662
  • [22] Cerebellar Exposure to Cell-Free Hemoglobin Following Preterm Intraventricular Hemorrhage: Causal in Cerebellar Damage?
    Alex Adusei Agyemang
    Kristbjörg Sveinsdóttir
    Suvi Vallius
    Snjolaug Sveinsdóttir
    Matteo Bruschettini
    Olga Romantsik
    Ann Hellström
    Lois E. H. Smith
    Lennart Ohlsson
    Bo Holmqvist
    Magnus Gram
    David Ley
    Translational Stroke Research, 2017, 8 : 461 - 473
  • [23] Cerebellar Exposure to Cell-Free Hemoglobin Following Preterm Intraventricular Hemorrhage: Causal in Cerebellar Damage?
    Agyemang, Alex Adusei
    Sveinsdottir, Kristbjorg
    Vallius, Suvi
    Sveinsdottir, Snjolaug
    Bruschettini, Matteo
    Romantsik, Olga
    Hellstrom, Ann
    Smith, Lois E. H.
    Ohlsson, Lennart
    Holmqvist, Bo
    Gram, Magnus
    Ley, David
    TRANSLATIONAL STROKE RESEARCH, 2017, 8 (05) : 461 - 473
  • [24] New Perspectives on the Importance of Cell-Free DNA Biology
    Bronkhorst, Abel J.
    Ungerer, Vida
    Oberhofer, Angela
    Gabriel, Sophie
    Polatoglou, Eleni
    Randeu, Hannah
    Uhlig, Carsten
    Pfister, Heiko
    Mayer, Zsuzsanna
    Holdenrieder, Stefan
    DIAGNOSTICS, 2022, 12 (09)
  • [25] Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases
    Duvvuri, Bhargavi
    Lood, Christian
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [26] The Role of Plasma Cell-Free Mitochondrial DNA and Nuclear DNA in Systemic Lupus Erythematosus
    Lee, Hui-Ting
    Lin, Chen-Sung
    Pan, Siao-Cian
    Chen, Wei-Sheng
    Tsai, Chang-Youh
    Wei, Yau-Huei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2022, 27 (12):
  • [27] Dose Effect of Intraventricular Fibrinolysis in Ventricular Hemorrhage
    Staykov, Dimitre
    Wagner, Ingrid
    Volbers, Bastian
    Huttner, Hagen B.
    Doerfler, Arnd
    Schwab, Stefan
    Bardutzky, Juergen
    STROKE, 2011, 42 (07) : 2061 - 2064
  • [28] Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus
    Swystun, L. L.
    Mukherjee, S.
    Liaw, P. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (11) : 2313 - 2321
  • [29] Clearance of Cell-Free DNA: A Novel Target for Therapeutic Utilization in Multiple Systemic Disorders
    Zhang, Wenjun
    Jing, Xuan
    Li, Bing
    Wu, Xiuping
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2025,
  • [30] Circulating cell-free DNA and its clinical utility in cancer
    Salviano-Silva, Amanda
    Maire, Cecile L.
    Lamszus, Katrin
    Ricklefs, Franz L.
    JOURNAL OF LABORATORY MEDICINE, 2022, 46 (04) : 265 - 272